Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change
02/26/02	€0.6330	+7.65%
01/26/01	€0.5880	-1.18%
30/26/30	€0.5950	0.00%
29/26/29	€0.5950	-4.19%
26/26/26	€0.6210	+0.16%

Delayed Quote Deutsche Boerse AG

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Delayed Deutsche Boerse AG Other stock markets 11:31:23 02/07/2026 am IST			5-day change	1st Jan Change
0.6330 ^EUR	+7.65%		+2.10%	-

19/06	Claude Lenoir appointed interim chairman of Theraclion
19/06	Theraclion Chairman Steps Down; Interim Successor Named	MT

Market Cap	4.92Cr 5.6Cr 4.53Cr 4.22Cr 7.96Cr 532.78Cr 8.12Cr 54Cr 21Cr 261.52Cr 21Cr 21Cr 910.15Cr	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	5.71Cr 6.5Cr 5.25Cr 4.89Cr 9.23Cr 617.8Cr 9.42Cr 63Cr 24Cr 303.25Cr 24Cr 24Cr 1.06TCr	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.37%	Yield 2024 *	-	Yield 2025	-

19/06	Claude Lenoir appointed interim chairman of Theraclion
19/06	Theraclion Chairman Steps Down; Interim Successor Named	MT
18/06	Theraclion Announces Board Changes	CI
09/06	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
05/06	Theraclion deploys first Sonovein system in China
05/06	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
05/06	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
05/06	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
01/06	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
11/05	Bouygues, Euronext, Vallourec... stocks to watch today in Paris
11/05	Theraclion raises nearly 6 million euros via units with warrants
20/04	France's Theraclion Targets EUR6 Million via Capital Increase	MT
20/04	Casino, Rubis, Sanofi... stocks to watch today in Paris

18/06	Theraclion Announces the Evolution of Its Board of Directors	BU
08/06	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU
04/06	Theraclion Announces First Clinical Deployment of Sonovein® in Hainan, China	BU
01/06	Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein® SpeedPulse Were Presented	BU
11/05	Theraclion : Inside Information / Other news releases	PU

Theraclion Share Price Deutsche Boerse AG

Stocks

941

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Course Extremes

Managers and Directors: Theraclion

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

19/06	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer
19/06	Les puces américaines en weekend prolongé
19/06	Claude Lenoir nommé président par intérim de Theraclion
18/06	THERACLION ANNONCE L’ÉVOLUTION DE SON CONSEIL D'ADMINISTRATION
13/06	Agenda des dividendes et des AG France : GTT, Alten et Exail sur les tablettes

1 week	0.59	0.63
1 month	0.59	0.93
Current year	0.44	0.93
1 year	0.44	0.93
3 years	0.44	0.93
5 years	0.44	0.93
10 years	0.44	0.93

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Gaylord Tallec COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Renaud Saleur BRD	Director/Board Member	-	01/02/2018
Ari Kellen BRD	Director/Board Member	-	13/02/2019
Shawn Langer BRD	Director/Board Member	-	13/02/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	+7.65%	+2.10%	-	-	5.6Cr
THERMO FISHER SCIENTIFIC, INC.	+2.39%	+4.29%	+21.80%	-1.61%	19TCr
INTUITIVE SURGICAL, INC.	+1.18%	+0.14%	-25.21%	+17.68%	14TCr
DANAHER CORPORATION	+1.70%	+2.57%	-3.67%	-19.28%	14TCr
BOSTON SCIENTIFIC CORPORATION	+0.89%	-3.15%	-58.90%	-20.39%	6.4TCr
EDWARDS LIFESCIENCES CORPORATION	+1.69%	+2.60%	+19.19%	-2.48%	5.3TCr
SIEMENS HEALTHINEERS AG	-0.51%	-0.61%	-27.90%	-32.54%	4.38TCr
AGILENT TECHNOLOGIES, INC.	+0.42%	+1.34%	+10.74%	+10.93%	3.77TCr
WATERS CORPORATION	+0.82%	+2.42%	+5.91%	+41.87%	3.71TCr
GE HEALTHCARE TECHNOLOGIES INC.	+1.33%	-0.03%	-14.60%	-20.16%	2.95TCr
Average	+1.67%	+2.37%	-8.07%	-2.89%	8.17TCr
Weighted average by Cap.	+1.29%	+3.37%	-5.06%	-2.62%

	2024	2025
Net sales	8L 9L 8L 7L 13.43L 8.99Cr 13.7L 91.91L 35.61L 4.41Cr 35.5L 34.74L 15Cr	7L 7L 6L 6L 10.55L 7.06Cr 10.76L 72.18L 27.97L 3.47Cr 27.88L 27.28L 12Cr
Net income	-57.57L -65.57L -52.99L -49.38L -93.13L -62Cr -95.02L -6.37Cr -2.47Cr -31Cr -2.46Cr -2.41Cr -106.5Cr	-56.9L -64.81L -52.37L -48.8L -92.04L -62Cr -93.91L -6.3Cr -2.44Cr -30Cr -2.43Cr -2.38Cr -105.25Cr
Net Debt	34.11L 38.85L 31.39L 29.25L 55.17L 37Cr 56.29L 3.78Cr 1.46Cr 18Cr 1.46Cr 1.43Cr 63Cr	78.52L 89.43L 72.27L 67.35L 1.27Cr 85Cr 1.3Cr 8.69Cr 3.37Cr 42Cr 3.36Cr 3.29Cr 145.25Cr